Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia (Q34662857)

3 August 2017

1 reference

title

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia (English)

1 reference

stem cell transplantation

3 August 2017

0 references

1 reference

1 reference

Dreger P

1 reference

3 August 2017

Montserrat E

series ordinal

1 reference

3 August 2017

publication date

1 June 2002

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

985-992

1 reference

Re: Stem cell transplant numbers decline; research continues

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leuk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

1 reference

7 January 2021

Allogeneic and autologous transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

In vivo 'Purging' of residual disease in CLL with Campath-1H

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402530

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402530

1 reference

Dimensions Publication ID

3 August 2017

1031833898

0 references

1 reference